Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

The discovery marks a significant step toward achieving a functional cure for HIV. A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

But there is no cure for HIV or AIDS or a vaccine for human use to prevent infection. One of the labs involved in current research to design such a vaccine is at La Jolla-based Scripps Research, which ...

2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a ... Updated Hep B Vaccine More Effective for ...

When they carried out the experiments on blood from animals that had received multiple doses of an experimental HIV vaccine, they discovered that some of the antibodies were not binding directly ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has uncovered a disturbing trend of free codeine ...

Sports became a sanctuary for HIV-positive youth through the ‘Champion in Me’ initiative, empowering them to break free from ...

For the next four years, the relationship between the United States and Africa will not be favourable. We must brace for tougher and rougher ...

The National Agency for Food and Drug Administration and Control has intensified its enforcement efforts against the sale of ...

This exhibition from the National Library of Medicine tells the history of AIDS and HIV, from initial discovery, to scientists and public health officials racing to understand how it spread ...

Technically known as tigilanol tiglate, EBC-46 was discovered a decade ago through ... diseases including AIDS (the advanced stage of HIV infection), cancer, and Alzheimer's.